Personalized Lung Cancer Treatment
Personalized Lung Cancer Treatment can be planned based on many factors, such as the patient’s overall health, stage of the disease, type of cancer, and cancer biomarkers. The current health status and treatment needs of each cancer patient are different.
While applying Personalized Lung Cancer Treatment, rather than the standard of care procedures, the condition of the person is examined in detail, according to the tumor type, stage, and biomarkers. Therefore, lung cancer treatment should be done under the control of a fully equipped hospital and an expert, specialized physician staff.
What is Personalized Lung Cancer Treatment?
For example, a curative treatment is often not possible for a patient with metastatic non-small cell lung cancer stage 4. Instead, the spread of cancer should be slowed down, and the treatment goals is to have patient’s quality of life improved. Clinical trials may be a better option for some patients at this point.
Today there are many more options compared to a few years ago, including genomic testing, targeted treatments, immunotherapy, and clinical trials. When deciding what to do, the number of tumors, their location, and your overall health come into play. Massive Bio helps bring first-class healthcare to cancer patients, including clinical trials and genomic testing.
Regardless of your geographical location or past medical history, adapted to your specific type of cancer, you can participate in a clinical trial that has been examined and agreed on by specialists, using artificial intelligence and expert decision support. Find information about treatment options for defeating lung cancer in the following article.
When diagnosed at an early stage, surgical intervention is one of the treatment methods that can save lives for cancer patients. The type of surgery depends on the location of the cancer in the lung and the purpose is to remove a small piece of lung. If only one lobe is taken surgically from the lung, it is called a lobectomy, and if one of the right or left lungs is taken, it is called pneumonectomy. However, some tumors cannot be operated due to their location, size, stage, as well as the general health of the patient.
Chemotherapy is another treatment method used in the treatment of lung cancer. The main goal is to destroy cancer cells with medication, usually involving a drug combination. Based on the general condition, age, tumor type and stage of the cancer determines whether or not a patient will receive chemotherapy as well as the duration of the treatment.
Radiotherapy is the use of rays to kill cancer cells in the limited area of the tumor. Radiotherapy can be applied before surgery to shrink a tumor or after to destroy any existing cancer cells. Radiotherapy is often used as the first alternative for patients who have advanced regionally but have not spread to any remote area, and it is sometimes combined with chemotherapy. It is also used for the relief of symptoms of lung cancer such as shortness of breath and pain in patients during advanced stages.
Immunotherapy and Targeted Therapy
Over the past few years, immunotherapy, and personalized lung cancer targeted therapy, have been routinely given in the treatment of lung cancer. In recent years, it can also be used as a first-line treatment for non-small cell lung cancers in advanced stage patients, if pathology reports, genomics and other biomarkers are appropriate. For example, EGFR, ALK, ROS, MET, BRAF, ERBB2, NTRK and PD-L1 are known markers, and many clinical trials are in development.
Vaccine and Clinical Research
Vaccine applications have been used in lung treatment for the last 5 years. It is a treatment method used for non-small cell stage 4 lung cancer patients. It is applied in combination with other treatments. Clinical studies are experimental studies that lead to many approved treatments today. You can decide with your doctor whether you are eligible for a clinical trial.